Cells were transfected with siRNA using
Lipofectamine RNAiMAX (Invitrogen cat. no. 13778-150) according to the manufacturer’s instructions. Briefly, a dilution of siRNA and Lipofectamine was made using
OPTI-MEM I 1× (GIBCO, cat. no. 31985-047) and then added to the cells. After 4 h, the medium was removed and fresh complete DMEM medium was added. Cells were allowed to grow for 24 h before repeating the siRNA transfection. Forty-eight hours after the second transfection, inhibition levels were assessed using western blot. The following siRNAs were used: Luciferase (5′-CGUACGCGGAAUACUUCGA-3′), EDC4-1 (5′-CAUAUCACCUGCUGCAGCA-3′), EDC4-2 (5′-CAGGAAUACUUGCAGCAGCUA-3′), EDC4-3 (5′-CACUGAAGGCCAGCAGACAG-3′), FANCD2 pool (5′-CCUCGACUCAUUGUCAGUCAACUAA-3′/5′-CCAUGUCUGCUAAAGAGCGUUCAUU-3′/5′-GGUGAUGGAUAAGUUGUCGUCUAUU-3′), BRCA1 (5′-GUGGGUGUUGGACAGUGUA-3′), BRCA2 (5′-GGAUUAUACAUAUUUCGCA-3′), and DCP1a (SMARTpool J-021242-08, GE Healthcare).
Hernández G., Ramírez M.J., Minguillón J., Quiles P., Ruiz de Garibay G., Aza-Carmona M., Bogliolo M., Pujol R., Prados-Carvajal R., Fernández J., García N., López A., Gutiérrez-Enríquez S., Diez O., Benítez J., Salinas M., Teulé A., Brunet J., Radice P., Peterlongo P., Schindler D., Huertas P., Puente X.S., Lázaro C., Pujana M.À, & Surrallés J. (2018). Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1. Nature Communications, 9, 967.